FINHUB Insights

AMGN · Q4 FY25 · Oct 1 – Dec 31, 2025

Amgen Q4 FY25: where the revenue came from and where it went

Amgen Q4 FY25: revenue $9.9B (+9% year over year). Net profit $1.3B. The whole income statement as a sankey diagram from the SEC filing.

Period
Oct 1 – Dec 31, 2025
Reported
Feb 13, 2026 10-K
Sankey diagram of Amgen's income statement for Q4 FY25: revenue of $9.9 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$9.9B +9% year over year
Gross profit$6.9B 70% margin
Operating profit$2.7B 28% margin
Net profit$1.3B 14% margin

The numbers

All figures in billions of U.S. dollars, for Q4 FY25 (period ends Dec 31, 2025).
ItemValueShare of revenueYear over year
Revenue 9.9 100% +9%
Cost of revenue−3.030%
Gross profit6.970% margin+4pp
SG&A−2.020%−1pp
Other−2.222%+0pp
Operating profit2.728% margin+2pp
Tax−0.2
Interest & other costs−1.2
Net profit1.314%+7pp
Filing on EDGAR More quarters of AMGN

Source of the numbers: tables in the filing (10-K). The diagram is generated automatically and checked against EDGAR before release. The fourth quarter has no column of its own in an annual report, so it is the full year minus the first nine months. How we calculate it → About and methodology.